Lee's Pharm (HKG:0950) 2011 net profit $84M, up 45%; div 3 ct - ResearchInChina

Search by Type

Report Charts News

*

Search by Company

Code Company name

Category

Home>>News>>Life Sciences>>Biotechnology>>Biologicals

Remember Me Next Time

Lee's Pharm (HKG:0950) 2011 net profit $84M, up 45%; div 3 ct

Date:2012-03-21

Related Company

Lee's Pharmaceutical Holdings Limited(00950.HK)

Results of Lee's Pharmaceutical Holdings (HKG:0950) for the fiscal year ended 31 December 2011:

Net profit: HK$83.906M, up 44.6% YoY
EPS: HK 17.9 cents
Final dividend: HK 3 cents

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Heparin Industry Report, 2010-20112011-09-28
China Blood Products Industry Report, 2010-20112011-09-05
China Monoclonal Antibody Industry Report, 2010-20112011-07-05
China Insulin Industry Report, 20102011-01-25
China Heparin Industry Report, 20102010-12-18
China Blood Products Industry Report, 20102010-11-10
Global and China Biopharmaceutical Industry Report, 20102010-09-16
China Blood Products Industry Report, 20092009-10-13

Related News

Lee's Pharm (HKG:0950) 2011 net profit $84M, up 45%; div 3 ct2012-03-21
BMS Banks on Innovative Drugs to Double China Sales2012-03-02
Agilent introduces first DNA methylation target-enrichment system2012-02-16
Genetic Technologies receives CLIA Certificate of Compliance2012-02-16
United Gene (HKG:0399) Expects Loss for 1H2012-02-15
Jubilant, Endo Pharmaceuticals announce early milestones in joint project2012-02-10
IDT acquires 1st BASE oligonucleotide business2012-02-10
Agilent expands chromatography product base2012-02-07

Contact us | Copyright | Privacy policy | Buy Reports | Member Service | Mailing List

2005-2011 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1